✦ LIBER ✦

Multiple courses of alefacept for the treatment of psoriatic nail disease in patients with chronic plaque psoriasis

Book ID: 116582596
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 54 KB
Volume: 56
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2006.10.537

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The efficacy of multiple courses of alef

The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis

✍ Alan Menter; Jennifer C. Cather; Diane Baker; Harold F. Farber; Mark Lebwohl; Mo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Sustained long-term remission of chronic

Sustained long-term remission of chronic plaque psoriasis upon treatment with multiple courses of alefacept

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

An extended 16-week course of alefacept

An extended 16-week course of alefacept for the treatment of chronic plaque psoriasis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

An extended 16-week course of alefacept

An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis

✍ Carin H. Gribetz; Robin Blum; Christopher Brady; Steven Cohen; Mark Lebwohl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 109 KB

The safety profile and sustained remissi

The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis

✍ Janet L. Roberts; Jean-Paul Ortonne; Jerry K.L. Tan; Eileen Jaracz; Ellen Franke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 408 KB

Repeat courses of intravenous alefacept

Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy

✍ Nick J. Lowe; John Gonzalez; Jerry Bagel; Ivor Caro; Charles N. Ellis; Alan Ment 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

## Abstract **Background** Psoriasis is a chronic, relapsing skin disease that may require multiple treatment courses. Alefacept targets the memory T cells implicated in psoriasis pathogenesis. This open‐label study evaluated the safety and tolerability, efficacy, and pharmacodynamics of repeat cou